FDA has granted priority review for Boehringer Ingelheim’s zongertinib NDA for treating unresectable or metastatic NSCLC.

To understand the key launch trends in 2024, GlobalData reviewed a sample of innovative drugs that were both approved and ...

U.S. President Donald Trump will meet on Thursday with chief executives from major drugmakers, a White House official ...

His proposal could prevent pharmacy benefit managers from inflating medication costs by banning spread pricing.

In the past week, a Boston biotech led by longtime industry CEO Harvey Berger said it plans to shut down, while another ...

Pfizer will end global development of its bleeding disorder gene therapy, Beqvez, the Nikkei reported on Thursday.

China’s share of the global drug development pipeline grew from 3% in 2013 to 28% in 2023, positioning China as the second-largest region for clinical trials after the United States. Additionally, the ...

The industry is on a strong growth trajectory, with experts predicting notable achievements over the next decade. Forecasts ...

Prescription totals for Attruby, which is locked in a closely watched commercial battle with Pfizer’s tafamidis, have more ...

Senate Bill 140 implements a variety of reforms, including one that addresses concerns about what’s known as vertical ...

10 Concentrations Evening and weekend classes Online, hybrid, and in-person options 2 campus locations (Newark and New Brunswick) 3 semester start options (Fall, Spring, or Summer) Considering an ...

The post World War 1 depression prompted Bristol-Myers to abandon its pharmaceutical business and devote its self to specialities, including Sal Hepatica and Ipana, along with a dozen or so ...